Eli Lilly's arthritis drug fails to meet main goal of late-stage COVID-19 study – Reuters

Eli Lilly’s arthritis drug fails to meet main goal of late-stage COVID-19 study – Reuters

Eli Lilly and Co and Incyte Corp said their rheumatoid arthritis drug baricitinib did not meet the main goal of preventing progression to mechanical ventilation in hospitalized COVID-19 patients under a late-stage study.

Read More…

You May Also Like